title: Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors.
authors.affiliation: Translational Oncology Research Centre, Department of Histopathology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK.
authors.forename: Federica
authors.initials: F
authors.lastname: Di Nicolantonio
authors.forename: Louise A
authors.initials: LA
authors.lastname: Knight
authors.forename: Silvana
authors.initials: S
authors.lastname: Di Palma
authors.forename: Sanjay
authors.initials: S
authors.lastname: Sharma
authors.forename: Pauline A
authors.initials: PA
authors.lastname: Whitehouse
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Mercer
authors.forename: Peter A
authors.initials: PA
authors.lastname: Charlton
authors.forename: David
authors.initials: D
authors.lastname: Norris
authors.forename: Ian A
authors.initials: IA
authors.lastname: Cree
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010619:Phenazines / Q000008:administration & dosage*; D018709:Statistics, Nonparametric; D014407:Tumor Cells, Cultured
chemical_list: C446952:4-methoxybenzo(a)phenazine-11-carboxylic acid (2-(dimethylamino)-1-methylethyl)amide; D010619:Phenazines